SCHEMBL4607748

SCHEMBL4607748

O=C(O)C(I)=C(OC(F)(F)F)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.42
F2 P00734 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 4/20 0.35
CES2 O00748 2/20 0.35
ALDH1A1 P00352 2/20 0.35
DAO P14920 1/20 0.35
NAPRT Q6XQN6 1/20 0.35
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TDP1 Q9NUW8 3/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
PARP1 P09874 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206047 0.74 ELANE (0.43) CES1F2LMNATSHRCES2
SCHEMBL219676 0.72 LMNA (0.56) CES1F2LMNATSHRCES2
Hydrochloric Acid SCHEMBL6620902 0.71 LMNA (0.54) CES1F2LMNATSHRCES2
SCHEMBL28123902 0.71 LMNA (0.54) CES1F2LMNATSHRCES2
SCHEMBL29319502 0.68 CES1 (0.48) CES1F2LMNATSHRCES2
SCHEMBL27630004 0.68 CES1 (0.44) CES1F2LMNATSHRCES2
SCHEMBL7146887 0.67 TDP1 (0.50) CES1F2LMNATSHRCES2
SCHEMBL3808088 0.67 GAA (0.53) LMNANPC1RAB9AL3MBTL1GAA
SCHEMBL7153126 0.66 CES1 (0.44) CES1F2LMNATSHRCES2
SCHEMBL16618550 0.65 CES1 (0.41) CES1F2LMNATSHRCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948623-A2 HETEROCYCLIC AMIDE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES Janssen Pharmaceutica, N.V. (BE) 2008-07-30 EP disclosed
WO-2007041077-A2 HETEROCYCLIC AMIDE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-12 WO disclosed